New research presented at the International Society for Stem Cell Research (ISSCR) 2026 Annual Meeting explores an approach ...
New research presented today at the International Society for Stem Cell Research (ISSCR) 2026 Annual Meeting explores an ...
Morning Overview on MSN
The FDA cleared donor immune cells to shield blood-cancer patients from deadly complications
Adults with blood cancers who need a stem-cell transplant from a matched donor now have a new option to prevent one of the ...
Novel allogeneic T-cell-based immunotherapy reduces chronic graft-versus-host disease (GVHD) in patients with blood cancers ...
CHICAGO — Ten people with type 1 diabetes, who had recurrent severe hypoglycemia and hypoglycemic unawareness, have remained insulin-independent for over a year following allogeneic stem cell-derived ...
The impact of the use of hypomethylating agents prior to reduced intensity conditioning allogeneic bone marrow transplant among patients with MDS. This is an ASCO Meeting Abstract from the 2025 ASCO ...
A patient with type 1 diabetes received genetically modified allogeneic islets and no immunosuppression. Results obtained ...
FCA lymphodepletion produced dose-limiting toxicities, including grade 3 autoimmune hepatitis and fatal hyperinflammatory ...
Knoepfler is professor of cell biology and human anatomy at UC Davis School of Medicine. Welcome to Lab Dish, a new First Opinion column on regenerative medicine from Paul Knoepfler. I’m upbeat about ...
Fifth patient treated with CER-1236 underwent stem cell transplant following lack of response to prior therapies; Company initiates third planned cohort in ongoing Phase 1 study in hematologic maligna ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results